Ryvu Therapeutics Sa

This study is testing a new drug, RVU120, given alone or with an existing drug (ruxolitinib), for adults with intermediate or high-risk myelofibrosis, a serious bone marrow cancer. The main goal is to see if the treatment can shrink enlarged spleens and improve symptoms in patien…

This study is testing a new drug called MEN1703 to see if it can help control aggressive B-cell lymphoma that has returned or hasn't responded to other treatments. It will be given alone to patients who have exhausted all standard options, and combined with another drug (glofitam…